416403
Position
Senior VP for Corporate Development and Strategy
Location
Carmel IN UNITED STATES
Bio
Mr. Mackison has over 15 years of pharmaceutical and life sciences experience in corporate development and strategy, mergers and acquisitions and finance. Prior to Assembly, he was Senior Director, Corporate Investment Life Sciences for Jabil, where he was responsible for healthcare M&A and venture investments. Prior to Jabil, Mr. Mackison founded and served as Managing Director of Oakridge Bioventures, a pharmaceutical strategy and M&A advisory firm, where he advised and co-founded startup companies. Previously, Mr. Mackison served as Divisional Director of Corporate Strategy and Senior Director, New Ventures at Lundbeck in Copenhagen. Prior to Lundbeck, Mr. Mackison was Director, Corporate Development and M&A with Ovation Pharmaceuticals, which was acquired by Lundbeck in 2009. Earlier in his career, Mr. Mackison held positions of increasing responsibility in finance at Pfizer and Eli Lilly and Co. He earned a BS in Finance from Indiana University.
Agenda
emergingopp_icon

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Michael ChanSenior VP atHKEX Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanPartner atSidley Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atFosun Pharma USA Haishan XiongSenior Vice President for Business Development atFountain Medical Development, Ltd GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.
Interests
None yet.